Published in J Bone Joint Surg Br on February 01, 2008
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nat Rev Drug Discov (2010) 1.33
Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study. Int Orthop (2008) 1.03
Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery. Thrombosis (2010) 0.82
The provision of total hip replacement for displaced intracapsular hip fractures. Ann R Coll Surg Engl (2016) 0.80
Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence population. Knee Surg Relat Res (2013) 0.79
Mechanical prophylaxis after hip fracture: what is the risk of deep vein thrombosis? A retrospective observational study. BMJ Open (2015) 0.75
Venous thromboembolism after total knee replacement or total hip replacement: what can be learnt from root-cause analysis? Ann R Coll Surg Engl (2016) 0.75
MINIATURE escherichia coli CELLS DEFICIENT IN DNA. Proc Natl Acad Sci U S A (1967) 19.02
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost (2007) 3.66
The properties of DNA transferred to minicells during conjugation. Cold Spring Harb Symp Quant Biol (1968) 2.86
Rate of mortality for elderly patients after fracture of the hip in the 1980's. J Bone Joint Surg Am (1987) 2.63
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37
Repair of radiation-induced damage to the cell division mechanism of Escherichia coli. J Bacteriol (1966) 2.23
Analytical techniques for cell fractions. V. Characteristics of the B-XIV and B-XV zonal centrifuge rotors. Anal Biochem (1967) 1.99
Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol (2006) 1.95
Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis (1984) 1.94
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res (2010) 1.93
DNA isolated from Escherichia coli minicells mated with F+ cells. Proc Natl Acad Sci U S A (1968) 1.83
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70
[Clinical diagnosis of deep venous thrombosis after hip replacement surgery]. Tidsskr Nor Laegeforen (1997) 1.67
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost (2005) 1.60
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost (2003) 1.57
Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br (2006) 1.56
Properties of a cell fraction that repairs damage to the cell division mechanism of Escherichia coli. J Bacteriol (1969) 1.45
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost (2006) 1.44
The design and operation of the B-IV zonal centrifuge system. Natl Cancer Inst Monogr (1966) 1.28
Polyuridylic acid-directed phenylalanine incorporation in minicell extracts. J Bacteriol (1969) 1.23
Stimulation of cell division by membrane-active agents. Biochem Biophys Res Commun (1973) 1.20
The incidence of the shock syndrome in a general hospital. Postgrad Med J (1974) 1.19
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. J Thromb Haemost (2004) 1.17
Isolation and characterization of rat macroglobulin. Natl Cancer Inst Monogr (1966) 1.12
Centrifugal separation of irradiated cultures of Escherichia coli cells into viable and nonviable populations. J Bacteriol (1976) 1.11
Membrane association of conjugally transferred deoxyribonucleic acid in Escherichia coli minicells. J Bacteriol (1971) 1.08
A circulating depressant effect following canine haemorrhagic shock. Br J Surg (1973) 1.06
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran. Thromb Res (2008) 1.05
Mechanism for the regulation of cell division in Agmenellum. J Bacteriol (1973) 1.03
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost (2007) 1.00
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med (2001) 1.00
The cleavage of biglycan by aggrecanases. Osteoarthritis Cartilage (2006) 0.99
Selective inhibition of deoxyribonucleic acid synthesis by 2-deoxyadenosine in the blue-green bacterium Agmenellum quadruplicatum. J Bacteriol (1972) 0.99
Serum alpha globulin fraction: survival-and-recovery effect in irradiated mice. Science (1967) 0.99
Surgical stabilisation of the rheumatoid cervical spine. A review of indications and results. J Bone Joint Surg Br (1987) 0.99
Neer total shoulder replacement in rheumatoid arthritis. J Bone Joint Surg Br (1987) 0.95
Thromboembolism--an academic concern or a clinical reality? Acta Orthop Scand (1999) 0.92
Cyclic changes in polyribosomes of synchronized Tetrahymena pyriformis. Exp Cell Res (1966) 0.92
No difference in mortality between cemented and uncemented hemiprosthesis for elderly patients with cervical hip fracture. A prospective randomized study on 334 patients over 75 years. Arch Orthop Trauma Surg (2013) 0.91
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
A bacteriologically occlusive clothing system for use in the operating room. J Bone Joint Surg Br (1983) 0.89
Problems and pitfalls of compression fixation of long bone fractures: a review of results and complications. Injury (1978) 0.86
Novel mutant impaired in cell division: evidence for a positive regulating factor. J Bacteriol (1973) 0.86
Pyrimidine dimer excision in surviving and nonsurviving cells of ultraviolet-irradiated cultures of Escherichia coli. J Bacteriol (1976) 0.85
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study. J Thromb Haemost (2009) 0.85
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study. J Thromb Haemost (2007) 0.85
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use. Int Angiol (2008) 0.83
Macromolecular synthesis and radiosensitivity in Escherichia coli. Radiat Res (1967) 0.83
Cell division mutations in the blue-green bacterium Agmenellum quadruplicatum strain BG1: a comparison of the cell wall. J Bacteriol (1972) 0.83
Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis. J Thromb Haemost (2013) 0.83
Myocardial blood flow and methabolism during and after hemorrhagic shock in the dog. Surg Gynecol Obstet (1973) 0.80
Stimulation of collagenase secretion from rheumatoid synovial tissue by human collagen peptides. J Bone Joint Surg Am (1982) 0.80
Cardiac sequelae of haemorrhagic shock. Br J Surg (1973) 0.79
Stimulation of cell division by croton oil in blue-green bacteria. J Bacteriol (1973) 0.77
Further studies on the effect of serum alpha macroglobulin on regeneration of hemopoietic tissue after x-irradiation. Radiat Res (1968) 0.77
[Thrombosis prevention after hip arthroplasty]. Tidsskr Nor Laegeforen (1998) 0.75
Low-molecular-weight heparin prophylaxis against thromboembolism after total hip replacement--the never-ending story? Acta Orthop Scand (2001) 0.75
Rigid internal fixation of fractures--a guide to management. Ann Acad Med Singapore (1982) 0.75
[Spigelian hernia misdiagnosed as inguinal hernia]. Tidsskr Nor Laegeforen (1988) 0.75
Separation of acid-soluble nucleotides from yeast with the nucleotide analyzer. Natl Cancer Inst Monogr (1966) 0.75
Cell synchrony. Science (1967) 0.75
[Acute pulmonary failure syndrome in adults]. Tidsskr Nor Laegeforen (1991) 0.75
An evaluation of cognitive-behavioral therapy for training resistance to visually-induced motion sickness. Aviat Space Environ Med (1989) 0.75
[Regional drug purchasing. Of what significance are equivalent drugs]. Tidsskr Nor Laegeforen (1996) 0.75
Thromboembolism and thromboprophylaxis in high risk surgery: facts and assumptions--a topic for emotions? Eur J Anaesthesiol (2000) 0.75
A gel-holding device for use with a guillotine-type gel slicer. Anal Biochem (1976) 0.75
[Automatic suture stapling in low rectal anastomosis. EEA and TA-55]. Tidsskr Nor Laegeforen (1986) 0.75
A circulating myocardial depressant factor after shock. Br J Surg (1973) 0.75
[Idiopathic omental infarction]. Tidsskr Nor Laegeforen (1988) 0.75
[The bone cement implantation syndrome]. Tidsskr Nor Laegeforen (1984) 0.75
[Automatic suture stapling in abdominal hysterectomy]. Tidsskr Nor Laegeforen (1986) 0.75